Table 1.
HPV vaccine completion rate among 378,484 commercially insured females who were aged 9 through 26 years and had at least one claim of HPV vaccination during 2009–2010 (N=378,484)
| Characteristics | HPV vaccine completion N, % |
Multivariable logistic regression model |
|||
|---|---|---|---|---|---|
| Adjusted OR | 95% CI | P-value | |||
| Age group at the 1st dose of HPV vaccination | |||||
| 9–10 (N=7358) | 2,416, 32.8% | 1.34 | 1.26 | 1.41 | <.0001 |
| 11–12 (N=84,046) | 27,041, 32.2% | 1.36 | 1.32 | 1.40 | <.0001 |
| 13–15 (N=111,947) | 32,790, 29.3% | 1.19 | 1.15 | 1.22 | <.0001 |
| 16–17 (N=65,660) | 18,741, 28.5% | 1.12 | 1.09 | 1.16 | <.0001 |
| 18–21 (N=67,838) | 17,667, 26.0% | 0.90 | 0.88 | 0.93 | <.0001 |
| 22–26 (N=41,635) | 12,631, 30.0% | Ref. | |||
| US census region | |||||
| Northeast (N=58,035) | 19,227, 33.1% | 1.07 | 1.05 | 1.09 | <.0001 |
| South (N=143,070) | 40,307, 28.2% | 0.83 | 0.81 | 0.84 | <.0001 |
| West (N=74,409) | 19,570, 26.3% | 0.79 | 0.78 | 0.81 | <.0001 |
| North Central (N=102,970) | 32,182, 31.3% | Ref. | |||
| Residence | |||||
| Urban (MSA) (N=335,670) | 98,879, 29.5% | 1.03 | 1.01 | 1.05 | 0.0146 |
| Rural (non-MSA) (N=42,814) | 12,407, 29.0% | Ref. | |||
| Health insurance plan | |||||
| CDHP (N=15,605) | 5,291, 33.9% | 1.25 | 1.21 | 1.30 | <.0001 |
| Comprehensive (N=3703) | 1,053, 28.4% | 0.96 | 0.89 | 1.04 | 0.3144 |
| EPO (N=7207) | 2,183, 30.3% | 1.06 | 1.01 | 1.12 | 0.0288 |
| HDHP (N=9,002) | 2,545, 28.3% | 0.96 | 0.91 | 1.01 | 0.1166 |
| POS (27,501) | 8,258, 30.0% | 1.05 | 1.02 | 1.09 | 0.0022 |
| POS capitation (N=2717) | 815, 30.0% | 0.98 | 0.90 | 1.07 | 0.6862 |
| PPO (N=243,531) | 71,703, 29.4% | 1.04 | 1.02 | 1.06 | 0.0002 |
| HMO (N=61,079) | 17,110, 28.0% | Ref. | |||
| Type of provider who administered the 1st dose | |||||
| Pediatric (N=161,813) | 46,344, 28.6% | 0.85 | 0.83 | 0.87 | <.0001 |
| OB/GYN (N=49,633) | 18,006, 36.3% | 1.73 | 1.68 | 1.78 | <.0001 |
| Others (N=112,855) | 31,101, 27.6% | 0.99 | 0.96 | 1.01 | 0.3055 |
| Primary care (N=54,183) | 15,835, 29.2% | Ref. | |||
| Quarter of the year at the 1st dose | |||||
| Jan–Mar (N=93,848) | 25,894, 27.6% | 1.01 | 0.99 | 1.04 | 0.2593 |
| Apr–Jun (N=93,625) | 31,671, 33.8% | 1.39 | 1.35 | 1.42 | <.0001 |
| Jul–Sep (N=131,567) | 36,423, 27.7% | 0.99 | 0.98 | 1.02 | 0.9459 |
| Oct–Dec (N=59,444) | 17,298, 29.1% | Ref. | |||
| Flu vaccination | |||||
| Yes (N=135,117) | 46,847, 34.7% | 1.55 | 1.52 | 1.57 | <.0001 |
| No (N=243,367) | 64,439, 26.5% | Ref. | |||
Abbreviations: HPV: human papillomavirus; MSA: Metropolitan Statistical Area; CDHP: consumer-driven health plan; EPO: Exclusive provider organizations; HDHP: high-deductible health plan; POS: point of service; PPO: Preferred provider organizations; HMO: Health maintenance organizations; OB/GYN: obstetrics and gynecology; OR: odds ratio; CI: confidence interval.